Loading menu…

Circulating Progesterone Levels and Ongoing Pregnancy Rates in Controlled Ovarian Stimulation Cycles in Assisted Reproduction Techniques

§ Kingston Hospital, NHS, London, UK

Send Message

To: Author

Circulating Progesterone Levels and Ongoing Pregnancy Rates in Controlled Ovarian Stimulation Cycles in Assisted Reproduction Techniques

Article Fingerprint

ReserarchID

E213T

Circulating Progesterone Levels and Ongoing Pregnancy Rates in Controlled Ovarian Stimulation Cycles in Assisted Reproduction Techniques Banner

Key Research Insights

Synthesized scholarly intelligence & interactive research assistant
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu
Reading Preferences
Font Size
Line Spacing
Background
This converted HTML version may contain rendering inconsistencies. Please refer to the PDF for the authoritative version, or click here to provide feedback.

Abstract

How can we prevent premature leutinization in our IVF cycles? To help find the solution a study designed with specific exclusion criteria in an assisted reproductive centre of a tertiary care hospital was designed. In a period of 2 years 100 patients were followed up prospectively. GnRH antagonist protocol was implemented for all recruits because of shorter duration of treatment and as it prevented hyperstimulation. Specific criteria was chosen for GnRH anatagonist initiation. Serum Progesterone measurements were used to predict premature leutinization. Electro-chemiluminiscence Immunoassay using COBAS 6000 used for the measurements. Three different groups analysed in above cohort and we concluded that despite of progesterone rise pregnancy outcome was unaffected. Why is the question answered in discussion.

References

22 Cites in Article
  1. 1. T Hoff,M Quigley,Ssc Yen (1983). Hormonal dynamics mid cycle: A reevaluation. J Clin Endocrinol Metab, 57, 792-801.
  2. 2. K Huang,E Muechler,K Schwarz,M Goggin,M Graham (1986). Serum progesterone levels in women treated with human menopausal gonadotropin and human chorionic gonadotropin for in vitro fertilization. Fertil steril, 46, 903.
  3. 3. A Halbersztadt,J Pajak,P Nowicki,I Jałocha (2006). Implantation and antigenicity of human endometrium. Postepy Hig Med Dosw, 60, 71-77.
  4. 4. R Legro,B Ary,R Paulson,F Stanczyk,M Sauer (1993). Pregnancy: Premature luteinization as detected by elevated serum progesterone is associated with a higher pregnancy rate in donor oocyte in-vitro fertilization. Human Reproduction, 8(9), 1506-1511.
  5. 5. C Venetis,E Kolibianakis,E Papinkalaou (2007). Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with probability of pregnancy in in vitro fertilization? A Survey Review And Meta-analysis. Hum Reprod, 13, 343-355.
  6. 6. J Younis,M Matilsky,O Radin,Ben (2001). Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization -embryo transfer cycles with long gonadotropin -releasing hormone agonist. Fertil Steril, 76, 294-299.
  7. 7. William Schoolcraft,Eleanor Sinton,Terry Schlenker,David Huynh,Fredesminda Hamilton,David Meldrum (1991). Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertility and Sterility, 55(3), 563-566.
  8. 8. Paulo Serafini,Bronte Stone,John Kerin,Joel Batzofin,Patrick Quinn,Richard Marrs (1988). Occurrence of a spontaneous luteinizing hormone surge in superovulated cycles—predictive value of serum progesterone. Fertility and Sterility, 49(1), 86-89.
  9. 9. M Dirnfeld,S Goldman,Y Gonen,M Koifman,A Lissak,H Abramovic (1993). A modest increase in serum progesterone levels on the day of human chorionic gonadotropin (hCG) administration may influence pregnancy rate and pregnancy loss in in vitro fertilization -embryo transfer patients. J Assist Repro Genet, 10(2), 126-130.
  10. 10. Marcelle Cedars,Eric Surey,Fredesminda Hamilton,Phillip Lapolt,David Meldrum (1990). Leuprolide acetate lowers circulating bioactive luteinizing hormone and testosterone concentrations during ovarian stimulation for oocyte retrieval. Fertility and Sterility, 53(4), 627-631.
  11. 11. E Adashi,C Resnick,D 'ercol E Aj,M Svoboda,J Van Wyk (1985). Insulin-like growth factors are intraovarian regulators of granulosa cell growth and functions. Endocr Rev, 6, 400-420.
  12. 12. H Jones (1985). Factors influencing implantation and maintenence of pregnancy following embryo transfer. Fertilization of the Human in vitro, 293.
  13. 13. N Spinks,O' Neill,C Collier,M Ryan,J (1987). Embryo derived platelet activating factor is essential in establishment of pregnancy in the mouse. Lancet, 1, 106.
  14. 14. Kaylen Silverberg,William Burns,David Olive,Robert Riehl,Robert Schenken (1991). Serum Progesterone Levels Predict Success ofin VitroFertilization/Embryo Transfer in Patients Stimulated with Leuprolide Acetate and Human Menopausal Gonadotropins*. The Journal of Clinical Endocrinology & Metabolism, 73(4), 797-803.
  15. 15. Michael Levy,David Smotrich,Eric Widra,Arthur Sagoskin,Denise Murray,Jerry Hall (1995). The predictive value of serum progesterone and 17-OH progesterone levels onin vitro fertilization outcome. Journal of Assisted Reproduction and Genetics, 12(3), 161-166.
  16. 16. F Ubaldi,M Camus,Smitz,H Bennink,A Van Steirteghem,P Devroey,R ; Fanchin,C Righini,F Olivennes,A Ferreira,R De Ziegler D, Frydman (1996). Consequences of premature progesterone elevation on the outcome of in vitro fertilization: Insights into a controversy. Fertil Steril, 68, 275-290.
  17. 17. R Fleming (2008). Progesterone elevation on the day of hCG: methodological issues. Human Reproduction Update, 14(4), 391-392.
  18. 18. E Bosch,E Labarta,J Crespo,C Simón,J Remohí,J Jenkins,A Pellicer (2010). Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Human Reproduction, 25(8), 2092-2100.
  19. 19. B Urman,C Alatas,S Aksoy,R Mercan,A Isiklar,B Balaban (1999). Elevated serum progesterone level on the day of hCG does not adversely affect implantation rates after intracytoplasmic sperm injection and embryo tranfer. Fertil Steril, 72, 975-979.
  20. 20. N Doldi,E Marsiglio,A Destafani,A Gessi,G Merati,A Ferrari (1999). Elevated serum progesterone on the day of HCG administration in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome. Human Reproduction, 14(3), 601-605.
  21. 21. Tasuku Harada,Chieko Katagiri,Naruhisa Takao,Toshiko Toda,Yasuyuki Mio,Naoki Terakawa (1996). Altering the timing of human chorionic gonadotropin injection according to serum progesterone (P) concentrations improves embryo quality in cycles with subtle P rise. Fertility and Sterility, 65(3), 594-597.
  22. 22. Michael Harper (1992). 10 The implantation window. Baillière's Clinical Obstetrics and Gynaecology, 6(2), 351-371.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Shailja Verma, Pratap Kumar. 2017. "Circulating Progesterone Levels and Ongoing Pregnancy Rates in Controlled Ovarian Stimulation Cycles in Assisted Reproduction Techniques". Global Journal of Medical Research - E: Gynecology & Obstetrics GJMR-E Volume 17 (GJMR Volume 17 Issue E1).

More Citation Formats

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords
Classification
GJMR-E Classification NLMC Code: WJ 190
Version of record
v1.2

Issue date
June 23, 2017

Language
English
Order Article Reprint
Experience in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 1K
Total Downloads: 76
All Trends

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Circulating Progesterone Levels and Ongoing Pregnancy Rates in Controlled Ovarian Stimulation Cycles in Assisted Reproduction Techniques

Shailja Verma
Shailja Verma Kingston Hospital, NHS, London, UK
Pratap Kumar
Pratap Kumar <p>Kingston Hospital, NHS, London, UK</p>